Table 3.
Association of high-risk HPV infection with variables associated with HIV infection
| High Risk HPV Infections | ||||
| Negative (32) N |
Positive (67) N |
Odds Ratio (95% CI) |
Adjusted Odds Ratio (95% CI)* |
|
| Years living with HIV | ||||
| <2 | 8 | 21 | 1 (ref) | 1 (ref) |
| 2 to 6) | 12 | 13 | 2.4 (0.8 – 7.5) | 3.0 (0.5 – 18.5) |
| 6+ | 12 | 33 | 2.5 (0.9 – 7.1) | 1.7 (0.3 – 9.2) |
| Duration of HAART therapy | ||||
| <3 | 12 | 42 | 1 (ref) | 1 (ref) |
| 3+ | 20 | 25 | 0.4 (0.1 – 0.9) | 0.4 (0.1 – 1.4) |
| CD4 count | ||||
| <400 | 11 | 57 | 1 (ref) | 1 (ref) |
| 400+ | 21 | 10 | 0.1 (0.03 – 0.2) | 0.2 (0.05 – 0.8) |
| HIV viral load | ||||
| <50 | 23 | 22 | 1 (ref) | 1 (ref) |
| 50 – 28,000 | 8 | 26 | 3.4 (1.3 – 9.1) | 1.9 (0.5 – 7.2) |
| >28,000 | 1 | 19 | 19.9 (2.4 – 161.3) | 2.2 (0.2 – 25.9) |
| Cervical cytology | ||||
| Negative | 29 | 25 | 1 (ref) | 1 (ref) |
| ASCUS | 1 | 6 | ||
| LGSIL | 2 | 29 | ||
| HGSIL | 0 | 6 | ||
ref = reference; *Adjusted for age (continuous), marital status, number of pregnancies, Tobacco use, duration of HAART therapy, CD4 counts, viral load and cervical cytology